Table of Contents
Preface
Chapter 1. Solid Lipid Nanoparticles as Innovative Strategies for the Treatment and Prophylaxis of Infectious Diseases
C. Rodríguez Laboccetta¹,², A. Videla Garrido², V. Briceño Fernández¹,², M. A. Toscanini¹,², A. D. Nusblat¹ and M. L. Cuestas²
¹Universidad de Buenos Aires, CONICET, Instituto de Nanobiotecnología (NANOBIOTEC), Buenos Aires, Argentina
²Universidad de Buenos Aires, CONICET, Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM), Buenos Aires, Argentina
Chapter 2. An Agent-Based Model of Infectious Diseases That Incorporates the Roles of Immune Cells and Antibodies
Shigeaki Ogibayashi
Chiba Institute of Technology, Chiba, Japan
Chapter 3. Endophytic Actinobacteria: A Source of Novel Bioactive Metabolites for the Treatment of Infectious Diseases
Juri Saikia¹,², Rajkumari Mazumdar¹,³ and Debajit Thakur¹
¹Microbial Biotechnology Laboratory, Life Sciences Division, Institute of Advanced Study in Science and Technology (IASST), Guwahati, India
²Department of Biotechnology, Gauhati University, Guwahati, India
³Department of Molecular Biology and Biotechnology, Cotton University, Guwahati, India
Chapter 4. Infectious Diseases: Antibiotic Resistance and Stewardship
Rajkumari Mazumdar¹,², Juri Saikia¹,³ and Debajit Thakur¹
¹Microbial Biotechnology Laboratory, Life Sciences Division, Institute of Advanced Study in Science and Technology (IASST), Guwahati, India
²Department of Molecular Biology and Biotechnology, Cotton University, Guwahati, India
³Department of Biotechnology, Gauhati University, Guwahati, India
Index
